Shedding from Normal and Cancer-Cell Surfaces
- 11 December 1980
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 303 (24), 1415-1416
- https://doi.org/10.1056/nejm198012113032411
Abstract
The release of products from cells is commonly called secretion. Secretion implies the release of the soluble contents of secretory vesicles by a process known as exocytosis. In recent years, however, it has become clear that exported products may be cell-surface molecules that are shed from cells. Shedding implies the release in soluble or particulate form of cell-surface constituents without an adverse effect on cell viability, and thus shedding should be distinguished from secretion.1 Proteins, glycoproteins, lipoproteins, glycolipids, and glycosaminoglycans, either alone or in combination with other cell-membrane constituents, may be shed. Although the precise mechanism of such release is . . .Keywords
This publication has 8 references indexed in Scilit:
- Shedding from the Cell Surface of Normal and Cancer CellsAdvances in Cancer Research, 1980
- Differences in intracellular distribution of plasminogen activator in growing, confluent, and transformed 3T3 cells.Proceedings of the National Academy of Sciences, 1979
- Interferon inhibits the release of plasminogen activator from SV3T3 cellsNature, 1978
- Cryoprecipitation of fibrin-fibrinogen complexes induced by the cold- insoluble globulin of plasmaBlood, 1978
- Plasminogen activator in early embryogenesis: Enzyme production by trophoblast and parietal endodermCell, 1976
- Spontaneous shedding and antibody induced modulation of histocompatibility antigens on murine lymphomata: Correlation with metastatic capacityBritish Journal of Cancer, 1976
- Platelet and Fibrinogen Consumption in ManNew England Journal of Medicine, 1972
- Chronic Intravascular Coagulation SyndromeNew England Journal of Medicine, 1968